Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

7.8%

18 terminated/withdrawn out of 232 trials

Success Rate

90.2%

+3.7% vs industry average

Late-Stage Pipeline

9%

21 trials in Phase 3/4

Results Transparency

49%

82 of 166 completed trials have results

Key Signals

19 recruiting82 with results13 terminated5 withdrawn

Enrollment Performance

Analytics

Phase 2
65(33.5%)
N/A
65(33.5%)
Phase 1
37(19.1%)
Phase 3
17(8.8%)
Early Phase 1
6(3.1%)
Phase 4
4(2.1%)
194Total
Phase 2(65)
N/A(65)
Phase 1(37)
Phase 3(17)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (232)

Showing 20 of 232 trials
NCT03961854Phase 2Completed

Lactobacillus Johnsonii in Children and Adolescents With T1D

Role: collaborator

NCT06300047Not ApplicableEnrolling By Invitation

Diabetes Transition Coordinator Study

Role: collaborator

NCT05594563Phase 2Recruiting

TArgeting Type 1 Diabetes Using POLyamines (TADPOL)

Role: collaborator

NCT05899439Recruiting

Immune Function and the Progression to T1D

Role: collaborator

NCT03999853Phase 1Completed

Butyrate Adjuvant Therapy for Type 1 Diabetes

Role: collaborator

NCT05463289Not ApplicableRecruiting

ACCESS 2: AI for pediatriC diabetiC Eye examS Study 2

Role: collaborator

NCT00690066Phase 2Completed

PROCHYMAL® (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)

Role: collaborator

NCT06305286Phase 1Recruiting

Safety, Tolerability, and Efficacy of Immunomodulation With A Monoclonal Antibody Against CD40L in Combination With Transplanted Islet Cells in Adults With Brittle Type 1 Diabetes Mellitus (T1D)

Role: collaborator

NCT02986984Recruiting

Transformative Research in Diabetic Nephropathy

Role: collaborator

NCT05904028Phase 3Recruiting

Home OCT-Guided Treatment Versus Treat and Extend for the Management of Neovascular AMD

Role: collaborator

NCT05145491Not ApplicableRecruiting

Randomized Trial Comparing Immediate vs. Deferred Surgery for Symptomatic ERM

Role: collaborator

NCT05949281Phase 2Active Not Recruiting

Repurposing Colchicine for Reduction of Residual Inflammatory Risk in Type 1 Diabetes

Role: collaborator

NCT05000021Not ApplicableRecruiting

Reducing Diabetes Distress Using Cognitive Behavioral Therapy in Young Adults With Type 1 Diabetes

Role: collaborator

NCT05742243Phase 2Completed

Insulin and Abatacept in Recently-diagnosed Type 1 Diabetes

Role: collaborator

NCT05727891Phase 2Active Not Recruiting

Evaluation of Tonabersat for DME

Role: collaborator

NCT04661358Phase 3Recruiting

Fenofibrate for Prevention of DR Worsening

Role: collaborator

NCT06172166Not ApplicableRecruiting

Transdisciplinary Care for Young Adults With Type 1 Diabetes

Role: collaborator

NCT03585153Enrolling By Invitation

Multicenter Assessment of the Pancreas in Type 1 Diabetes

Role: collaborator

NCT05734313Not ApplicableRecruiting

Telemedicine-Delivered Unified Protocol for Cognitive Behavioral Therapy for Anxiety and Depression

Role: collaborator

NCT06072326Phase 2Not Yet Recruiting

dApagliflozin SC0062 and Prevention of Renal Injury; a Randomized Evaluation

Role: collaborator